Andrew Zheng

Title: The Innovative Contributions of Andrew Zheng

Introduction

Andrew Zheng is a notable inventor based in Watchung, NJ (US). He has made significant strides in the field of biosensors, particularly through his innovative work on magnesium zinc oxide nanostructures. His contributions are vital in advancing the monitoring of cell populations in response to various agents.

Latest Patents

Andrew Zheng holds a patent for a "Magnesium zinc oxide nanostructure modified biosensor and monitoring of response of cell population to an agent using the same." This invention utilizes a magnesium zinc oxide (MZO) nanostructure modified quartz crystal microbalance (MZO-QCM). It combines the unique sensing ability and biocompatibility of MZO-based nanostructures with the dynamic impedance spectrum capability of bulk acoustic wave (BAW) devices, including QCM. This technology enables real-time, noninvasive, and label-free monitoring of cell populations, specifically targeting the susceptibility and resistance of bacterial and fungal strains, as well as cancer cells, to various antibiotic, antifungal, and anticancer drugs. Andrew Zheng has 1 patent to his name.

Career Highlights

Andrew Zheng is affiliated with Rutgers, the State University of New Jersey, where he continues to push the boundaries of research in biosensor technology. His work is characterized by a commitment to innovation and practical applications in healthcare.

Collaborations

Andrew has collaborated with notable colleagues, including Yicheng Lu and Pavel Ivanoff Reyes, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Andrew Zheng's contributions to the field of biosensors exemplify the impact of innovative thinking in addressing complex challenges in healthcare. His work not only enhances our understanding of cell responses but also paves the way for future advancements in medical technology.